Schedule 13G ownership disclosure

GW PHARMACEUTICALS PLC

Security class unavailable · CUSIP: 36197T103

Event date: 2018-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
28,955,761
Percent of class
7.9000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000858744-19-000010
Form type
SC 13G/A
Filer
GW PHARMACEUTICALS PLC
CIK
CIK 1351288
Filed
Feb 14, 2019
Reporting period
Dec 31, 2018
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub